Table 2.

Reported cases of myelofibrosis and lymphoproliferative disease.

	Sex/Age	Histology	MF degree	B-symptoms	Lymph nodes	SMG	HMG	LDH	Treatment	Response	FU (mo)	Outcome
Takai and Sanada [14]	F/65	T-NHL	marked	+	+	−	−	increased	CHOP	CR	9	A
Kimura et al. [15]	H/55	B-CLL	moderate to severe	na	+	+	+	na	COP, CLB	PR	11	A
Pulsoni et al. [13]	F/58	PCM	extensive	+	−	+	+	na	MP, VMCP-VBAP	PR, relapse	44	D
Orth [12]	F/55	T-NHL	na	na	+	+	+	na	Prednisone, Vincristine	PR	4	A
Meckenstock et al. [10]	H/36	B-NHL	diffuse	+	−	+	+	increased	corticosteroid	—	3	D
Weirich et al. [16]	H/42	T-NHL	marked, diffuse	+	−	+	+	na	CHOP, splenectomy	PR	2	A
Stevenson et al. [8]	F/60	PCM	diffuse	+	−	+	+	na	VAD, melphalan + ASCT	CR	24	A
Kasahara et al. [11]	F/68	B-NHL	marked	+	−	−	−	na	CHOP	< PR	na	D
Abe et al. [19]	F/19	T-NHL	diffuse	na	+	+	+	increased	CHOP	CR	24	A
Uehara et al. [9]	H/69	T-NHL	diffuse	−	+	+	na	increased	na	PR, relapse	30	D
Rao et al. [7]	F/46	T-NHL	marked	+	+	+	+	increased	Splenectomy CHOP and ICE	CR after ICE	11	A
Matsunaga et al. [6]	F/73	B-NHL	4+	+	−	+		increased	Splenectomy, fludarabine, cyclophosph	CR	12	D
Okabe et al. [4]	H/68	T-NHL	diffuse	na	−	+	−	N	Cyclophos, oncovin, prednisone	refractory	9	D
Hatta et al. [20]	H/67	B-NHL	NA	−	+	−	−	increased	na	refractory	14	D
Hagihara et al. [5]	H/68	B-NHL	NA	+	−	+	+	increased	CHOP	CR	na	A

A: alive; CR: complete remission; CLB: chlorambucil; CLL: chronic lymphocytic lymphoma; D: death; HMG: hepatomegaly; ICE: ifosfamide cytarabine etoposide; NHL: non-hodgkin lymphoma; PCM: plasma cell myeloma; na: not available; PR: partial remission; Prog: progressive; SMG: splenomegaly; +: present; −: absent.